P19-02. High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes
Morgane Bomsel(Centre National de la Recherche Scientifique), Sylvain Fleury(Cosmetics Europe), Nicolas Mouz(Abterra Biosciences (United States)), Rinaldo Zurbriggen, G Devillers(Becton Dickinson (France)), Anne-Sophie Drillet(Délégation Paris 5), Lucia Lopalco(Vita-Salute San Raffaele University), Marie G. Roger, Mario Amacker(University of Bern)
Cited by 0
Related Papers
Direct activation of TERT transcription by c-MYC
|Nature Genetics|1999|903
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
|Immunity|2011|285
Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
|PubMed|1991|247
Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells
|The Journal of Immunology|2000|244